Close Menu
Home » 23andMe Sues Ancestry for Patent Infringement, Misleading Marketing

23andMe Sues Ancestry for Patent Infringement, Misleading Marketing

May 14, 2018
|
staff reporter

NEW YORK (GenomeWeb) – 23andMe sued rival Ancestry.com on Friday in a California federal district court, alleging infringement of its patented method of identifying relatives in a database and of false advertising. The company also asked the court to nullify the trademarked "ancestry" logotype.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Walking Around

A Minnesota toddler given a gene therapy to treat her spinal muscular atrophy is now walking, according to Newsweek.

For Better Identification

NBC Bay Area reports a California lab has been certified to conduct forensic mitochondrial DNA sequencing.

There, In the Water

The New York Times reports on how environmental DNA sampling could monitor endangered species.

Cell Studies Look at Endometrial Cancer 'Omics, Antibiotic Discovery Deep Learning, Lymphoma

In Cell this week: proteomic, genomic, and transcriptomic analysis of endometrial cancer; deep neural network learning-based approach to antibiotic discovery; and more.

What's Popular?

In Business News

  1. MGI Unveils 'Extreme Throughput' Sequencing Platform at AGBT to Enable $100 Human Genome

  2. Guardant Health to Focus on Early Cancer Detection and Monitoring, CDx Development in 2020

    Premium

  3. Oxford Nanopore Licenses NuProbe Sample Prep Technology

  4. BioMérieux Reports 11 Percent Revenue Growth in Q4

  5. MDxHealth 2019 Revenues Fall 58 Percent

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.